![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1320996 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP6V1H mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1320996 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of ATP6V1H mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | RGD:1320996 | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1320996 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP6V1H mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP6V1H mRNA | CTD | PMID:33387578 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1320995 | 6480464 | Lactic Acid results in decreased expression of ATP6V1H mRNA | CTD | PMID:30851411 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1320996 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of ATP6V1H mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ATP6V1H mRNA | CTD | PMID:36041667 | acrylamide | increases expression | ISO | RGD:1320995 | 6480464 | Acrylamide results in increased expression of ATP6V1H mRNA | CTD | PMID:32763439 | Aflatoxin B2 alpha | decreases methylation | ISO | RGD:1320995 | 6480464 | aflatoxin B2 results in decreased methylation of ATP6V1H intron | CTD | PMID:30157460 | antimycin A | multiple interactions | ISO | RGD:1320995 | 6480464 | [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA | CTD | PMID:28366621 | atrazine | increases expression | ISO | RGD:1320995 | 6480464 | Atrazine results in increased expression of ATP6V1H mRNA | CTD | PMID:22378314 | benzo[a]pyrene | affects methylation | ISO | RGD:1320995 | 6480464 | Benzo(a)pyrene affects the methylation of ATP6V1H intron | CTD | PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATP6V1H mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ATP6V1H mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ATP6V1H mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ATP6V1H gene | CTD | PMID:28505145 | bisphenol F | multiple interactions | ISO | RGD:1320995 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of ATP6V1H gene | CTD | PMID:31601247 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ATP6V1H mRNA | CTD | PMID:36041667 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of ATP6V1H promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | ISO | RGD:1320996 | 6480464 | Cadmium Chloride results in increased expression of ATP6V1H mRNA | CTD | PMID:30030080 | carbon nanotube | increases expression | ISO | RGD:1320996 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cisplatin | affects response to substance | ISO | RGD:1320995 | 6480464 | ATP6V1H mRNA affects the susceptibility to Cisplatin | CTD | PMID:18610736 | cobalt dichloride | increases expression | ISO | RGD:1320995 | 6480464 | cobaltous chloride results in increased expression of ATP6V1H mRNA | CTD | PMID:19376846 | copper(II) sulfate | increases expression | ISO | RGD:1320995 | 6480464 | Copper Sulfate results in increased expression of ATP6V1H mRNA | CTD | PMID:19549813, PMID:20599845 | CU-O LINKAGE | decreases expression | ISO | RGD:1320996 | 6480464 | cupric oxide analog results in decreased expression of ATP6V1H protein | CTD | PMID:23882024 | CU-O LINKAGE | increases expression | ISO | RGD:1320995 | 6480464 | cupric oxide results in increased expression of ATP6V1H mRNA | CTD | PMID:22077320 | deoxynivalenol | decreases expression | ISO | RGD:1320995 | 6480464 | deoxynivalenol results in decreased expression of ATP6V1H protein | CTD | PMID:33890134 | dexamethasone | decreases expression | ISO | RGD:1320996 | 6480464 | Dexamethasone results in decreased expression of ATP6V1H mRNA | CTD | PMID:22185406 | ethanol | affects splicing | ISO | RGD:1320996 | 6480464 | Ethanol affects the splicing of ATP6V1H mRNA | CTD | PMID:30319688 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ATP6V1H mRNA | CTD | PMID:24136188 | formaldehyde | increases expression | ISO | RGD:1320995 | 6480464 | Formaldehyde results in increased expression of ATP6V1H mRNA | CTD | PMID:23649840 | fulvestrant | multiple interactions | ISO | RGD:1320995 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of ATP6V1H gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ATP6V1H mRNA | CTD | PMID:33387578 | hydrogen sulfide | decreases expression | ISO | RGD:1320996 | 6480464 | Hydrogen Sulfide results in decreased expression of ATP6V1H protein | CTD | PMID:29932956 | inulin | multiple interactions | ISO | RGD:1320996 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATP6V1H mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | RGD:1320995 | 6480464 | Ivermectin results in decreased expression of ATP6V1H protein | CTD | PMID:32959892 | lead diacetate | increases expression | ISO | RGD:1320996 | 6480464 | lead acetate results in increased expression of ATP6V1H mRNA | CTD | PMID:25270620 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of ATP6V1H mRNA | CTD | PMID:24136188 | leflunomide | increases expression | ISO | RGD:1320995 | 6480464 | leflunomide results in increased expression of ATP6V1H mRNA | CTD | PMID:28988120 | lipopolysaccharide | decreases expression | ISO | RGD:1320996 | 6480464 | Lipopolysaccharides results in decreased expression of ATP6V1H mRNA | CTD | PMID:22185406 | methyl methanesulfonate | increases expression | ISO | RGD:1320995 | 6480464 | Methyl Methanesulfonate results in increased expression of ATP6V1H mRNA | CTD | PMID:23649840 | mono(2-ethylhexyl) phthalate | affects expression | ISO | RGD:1320996 | 6480464 | mono-(2-ethylhexyl)phthalate affects the expression of ATP6V1H mRNA | CTD | PMID:21195148 | Monobutylphthalate | affects expression | ISO | RGD:1320996 | 6480464 | monobutyl phthalate affects the expression of ATP6V1H mRNA | CTD | PMID:21195148 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of ATP6V1H mRNA | CTD | PMID:24136188 | oligomycin A | multiple interactions | ISO | RGD:1320995 | 6480464 | [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA | CTD | PMID:28366621 | paracetamol | affects expression | ISO | RGD:1320996 | 6480464 | Acetaminophen affects the expression of ATP6V1H mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1320996 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP6V1H mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATP6V1H mRNA | CTD | PMID:36331819 | phosgene | affects expression | ISO | RGD:1320996 | 6480464 | Phosgene affects the expression of ATP6V1H mRNA | CTD | PMID:16300373 | pirinixic acid | multiple interactions | ISO | RGD:1320995 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATP6V1H mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | RGD:1320996 | 6480464 | pirinixic acid results in increased expression of ATP6V1H mRNA | CTD | PMID:23811191 | rac-lactic acid | decreases expression | ISO | RGD:1320995 | 6480464 | Lactic Acid results in decreased expression of ATP6V1H mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | RGD:1320995 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1H mRNA | CTD | PMID:23557933 | rotenone | increases expression | ISO | RGD:1320995 | 6480464 | Rotenone results in increased expression of ATP6V1H mRNA | CTD | PMID:31648047 | senecionine | increases expression | ISO | RGD:1320996 | 6480464 | senecionine results in increased expression of ATP6V1H protein | CTD | PMID:35357534 | sodium arsenite | increases expression | ISO | RGD:1320996 | 6480464 | sodium arsenite results in increased expression of ATP6V1H mRNA | CTD | PMID:25270620 | tetrachloromethane | increases expression | ISO | RGD:1320996 | 6480464 | Carbon Tetrachloride results in increased expression of ATP6V1H mRNA | CTD | PMID:31919559 | trichostatin A | increases expression | ISO | RGD:1320995 | 6480464 | trichostatin A results in increased expression of ATP6V1H mRNA | CTD | PMID:24935251 | trifluoperazine | multiple interactions | ISO | RGD:1320995 | 6480464 | [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA | CTD | PMID:28366621 | urethane | increases expression | ISO | RGD:1320995 | 6480464 | Urethane results in increased expression of ATP6V1H mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | ISO | RGD:1320995 | 6480464 | Valproic Acid results in decreased methylation of ATP6V1H gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1320995 | 6480464 | Valproic Acid results in increased expression of ATP6V1H mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | RGD:1320995 | 6480464 | Valproic Acid affects the expression of ATP6V1H mRNA | CTD | PMID:25979313 | Yessotoxin | increases expression | ISO | RGD:1320995 | 6480464 | yessotoxin analog results in increased expression of ATP6V1H mRNA | CTD | PMID:30679557 | |